Metformin Use on Incidence and Oncologic Outcomes of Bladder Cancer Patients With T2DM: An Updated Meta-Analysis

• প্রধান লেখক: Chen-Qian Liu (লেখক), Jian-Xuan Sun (লেখক), Jin-Zhou Xu (লেখক), Xiao-Yuan Qian (লেখক), Sen-Yuan Hong (লেখক), Meng-Yao Xu (লেখক), Ye An (লেখক), Qi-Dong Xia (লেখক), Jia Hu (লেখক), Shao-Gang Wang (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Frontiers Media S.A., 2022-04-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Background: The incidence rate and mortality of bladder cancer are increasing year by year. Interestingly, the commonly used metabolic regulatory drug metformin has been reported to have anti-tumor effect in recent years. Nevertheless, it keeps unclear whether the usage of metformin is beneficial or...